Target intelligence / Profile preview

Retinal antioxidant defense

Molecular classification
Other
01

Overview

The **retinal antioxidant defense** is not a single molecular entity but encompasses a variety of antioxidant systems present in retinal tissue, including enzymes such as superoxide dismutase, catalase, glutathione peroxidase, and regulatory pathways like NRF2[1][3]. These systems collectively work to remove reactive oxygen species (ROS) generated by high metabolic activity, light exposure, and inflammation within the retina, thereby protecting photoreceptors and retinal pigment epithelial cells from oxidative damage and subsequent cell death[1][3]. Dysfunction or overwhelming of these antioxidant defenses is implicated in the pathogenesis and progression of multiple retinal degenerative diseases, including AMD and retinitis pigmentosa[1][3]. Modulation of these antioxidant pathways, either through genetic or pharmacological means, is a promising area of research for therapeutic intervention in inherited and age-related retinal diseases[1][3][4]. In summary, "retinal antioxidant defense" is a broad, collective concept referring to the ensemble of antioxidative mechanisms in retinal tissue and is not, in itself, a canonical molecular drug target.

Other names
Retinal antioxidant systemRetinal antioxidant mechanismsAntioxidant enzymes in retina
02

Mechanism of action

Upregulation of antioxidant enzyme expression (e.g., via NRF2 pathway), Reduction of reactive oxygen species (ROS), Inhibition of oxidative damage, Modulation of redox signaling pathways

03

Biological functions

Oxidative stress protectionRedox homeostasis regulationCell survival promotionRegulation of cell deathPhotoreceptor protection
04

Disease associations

Retinal degenerationAge-related macular degeneration (AMD)Retinitis pigmentosaDiabetic retinopathyOther inherited retinal diseases
05

Safety considerations

Overexpression of isolated antioxidant enzymes can disrupt redox balance (e.g., increased hydrogen peroxide from excess superoxide dismutase)Off-target effects of systemic antioxidantsUnknown long-term impact of redox modulation
06

Interacting drugs

Sulforaphane

4 more in the full profile.

07

Biomarkers

Oxidative stress markers (e.g., 8-hydroxy deoxyguanosine (8-OHdG), thiobarbituric acid reactive substances (TBAR))Antioxidant enzyme levels (e.g., thioredoxin, catalase, superoxide dismutase)DNA/lipid/protein oxidation products

Beyond the preview

Go deeper on Retinal antioxidant defense.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinal antioxidant defense.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call